WHAT IS METASTATIC BLADDER CANCER?

Metastatic bladder cancer occurs when cancer cells spread from the bladder to distant organs such as lymph nodes, bones, lungs, liver, or other parts of the body. Today, treatment may include chemotherapy, immunotherapy, antibody-drug conjugates (ADCs), targeted therapies, and selected local treatments such as surgery or radiotherapy. According to the 2026 European Association of Urology (EAU) Guidelines, treatment should be individualized based on the patient’s overall health, extent of disease, previous treatments, molecular characteristics, and treatment goals.

TABLE OF CONTENTS

What is metastatic bladder cancer?

Where does bladder cancer usually spread?

What are the symptoms?

How is metastatic disease diagnosed?

What treatment options are available?

Immunotherapy and next-generation therapies

The EAU 2026 key message for patients

Multidisciplinary treatment planning with Assoc. Prof. Dr. Serdar Yalçın

Frequently Asked Questions

WHAT IS METASTATIC BLADDER CANCER?

Metastatic bladder cancer develops when cancer cells spread beyond the bladder to distant parts of the body.

The disease most commonly spreads through the lymphatic system or bloodstream and may involve several organs.

WHERE DOES BLADDER CANCER USUALLY SPREAD?

The most common sites of metastasis include:

• Lymph nodes

• Bones

• Lungs

• Liver

Less commonly, other organs may also be affected.

WHAT ARE THE SYMPTOMS?

Symptoms vary depending on the location of metastases and may include:

• Unintentional weight loss

• Persistent fatigue

• Bone pain

• Shortness of breath

• Abdominal pain

• Loss of appetite

Some patients may have few or no symptoms when metastases are first detected on imaging.

HOW IS METASTATIC DISEASE DIAGNOSED?

Diagnosis may include:

• Computed tomography (CT)

• Magnetic resonance imaging (MRI)

• PET/CT in selected patients

• Blood tests

• Biopsy when necessary to confirm metastatic disease

The choice of investigations depends on the clinical situation.

WHAT TREATMENT OPTIONS ARE AVAILABLE?

Current treatment options may include:

• Cisplatin-based chemotherapy

• Immunotherapy

• Antibody-drug conjugates (ADCs)

• Targeted therapies

• Supportive and palliative care

• Surgery or radiotherapy in selected patients

Treatment is tailored according to each patient’s disease characteristics and overall health.

IMMUNOTHERAPY AND NEXT-GENERATION THERAPIES

Major advances have transformed the treatment of metastatic bladder cancer in recent years.

Modern treatment options include:

• PD-1 and PD-L1 immune checkpoint inhibitors

• Enfortumab Vedotin

• Sacituzumab Govitecan

• Erdafitinib for patients with susceptible FGFR2/3 genetic alterations

Additional therapies may become available as new clinical evidence emerges.

THE EAU 2026 KEY MESSAGE FOR PATIENTS

Metastatic bladder cancer is no longer treated with a single standard approach.

According to the 2026 European Association of Urology (EAU) Guidelines, treatment should be individualized by a multidisciplinary team, and eligible patients should have access to modern systemic therapies whenever appropriate.

MULTIDISCIPLINARY TREATMENT PLANNING WITH ASSOC. PROF. DR. SERDAR YALÇIN

Assoc. Prof. Dr. Serdar Yalçın evaluates patients with metastatic bladder cancer in Bodrum, Türkiye, together with specialists in medical oncology, radiology, nuclear medicine, pathology, and other relevant disciplines.

Treatment options—including chemotherapy, immunotherapy, antibody-drug conjugates, targeted therapies, and selected surgical or radiotherapy approaches—are carefully individualized according to the latest European Association of Urology (EAU) Guidelines.

In addition to patients from Bodrum and the Muğla region, individuals from across Türkiye and abroad seek consultation for second opinions and advanced uro-oncological treatment planning.

Patients frequently highlight detailed communication, evidence-based recommendations, multidisciplinary decision-making, individualized treatment planning, and comprehensive support throughout every stage of care.

CONCLUSION

The treatment of metastatic bladder cancer has advanced significantly in recent years. Modern systemic therapies have improved survival and quality of life for many patients. The most appropriate treatment strategy should always be determined individually by an experienced multidisciplinary team.

FREQUENTLY ASKED QUESTIONS

Can metastatic bladder cancer be cured?

Long-term disease control is possible in selected patients, but treatment goals vary depending on the extent of disease and individual clinical circumstances.

Can immunotherapy be used for metastatic bladder cancer?

Yes. Immunotherapy is an important treatment option for appropriately selected patients according to current international guidelines.

Are the newest medications suitable for everyone?

No. Treatment selection depends on tumor biology, molecular characteristics, previous therapies, overall health, and approved clinical indications.

(Bu içerik Değişik Platformlar taranarak alıntılanmıştır)